Summary: A new study reports increased levels of STEP in the hippocampus is linked to mild cognitive impairment.
In mice, rats, monkeys, and people, aging can take its toll on cognitive function. A new study by researchers at Yale and Université de Montréal reveal there is a common denominator to the decline in all of these species — an increase in the level of the molecule striatal-enriched phosphatase, or STEP.
Increased levels of STEP in the hippocampus, a brain structure crucial to the formation of memory, were found in memory-impaired mice and rats, aged rhesus monkeys, and people suffering from mild cognitive impairment, the researchers report March 22 in the journal Current Biology.
High levels of STEP have also been reported in brains of Alzheimer’s patients, the authors note. STEP appears to play a key role in memory consolidation, but too much of it appears to be a bad thing. Young mice and rats with elevated levels of STEP perform more poorly on maze and other memory tests than their peers, and older animals in which STEP is inhibited perform more like young mice.
The scientists hypothesize that as we age we lose ability of to degrade STEP, leading to an unhealthy build up.
“The obvious follow up is to look for STEP inhibitors that will work in people,” said co-corresponding author Paul Lombroso, the Elizabeth Mears and House Jameson Professor in the Child Study Center and professor of neuroscience and of psychiatry.
[divider]About this neuroscience research article[/divider]
David Castonguay is lead author of the paper, and Jonathan Brouillette is co-corresponding author. Both are from the Université de Montréal.
Source: Bill Hathaway – Yale
Publisher: Organized by NeuroscienceNews.com.
Image Source: NeuroscienceNews.com image is adapted from the Yale press release.
Original Research: Open access research for”The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline” by David Castonguay, Julien Dufort-Gervais, Caroline Ménard, Manavi Chatterjee, Rémi Quirion, Bruno Bontempi, Jay S. Schneider, Amy F.T. Arnsten, Angus C. Nairn, Christopher M. Norris, Guylaine Ferland, Erwan Bézard, Pierrette Gaudreau, Paul J. Lombroso’Correspondence information about the author Paul J. Lombroso, and Jonathan Brouillette in Current Biology. Published online March 22 2018.
[divider]Cite This NeuroscienceNews.com Article[/divider]
[cbtabs][cbtab title=”MLA”]Yale “How Do We Lose Memory? A STEP at a Time.” NeuroscienceNews. NeuroscienceNews, 25 March 2018.
<https://neurosciencenews.com/step-memory-8681/>.[/cbtab][cbtab title=”APA”]Yale (2018, March 25). How Do We Lose Memory? A STEP at a Time. NeuroscienceNews. Retrieved March 25, 2018 from https://neurosciencenews.com/step-memory-8681/[/cbtab][cbtab title=”Chicago”]Yale “How Do We Lose Memory? A STEP at a Time.” https://neurosciencenews.com/step-memory-8681/ (accessed March 25, 2018).[/cbtab][/cbtabs]
The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline
•Increased STEP levels in aged memory-impaired mice, rats, monkeys, and aMCI people
•Genetic and pharmacological reduction of STEP improved memory performance in rodents
•Viral-mediated STEP overexpression in the hippocampus induced memory impairments
Cognitive disabilities that occur with age represent a growing and expensive health problem. Age-associated memory deficits are observed across many species, but the underlying molecular mechanisms remain to be fully identified. Here, we report elevations in the levels and activity of the striatal-enriched phosphatase (STEP) in the hippocampus of aged memory-impaired mice and rats, in aged rhesus monkeys, and in people diagnosed with amnestic mild cognitive impairment (aMCI). The accumulation of STEP with aging is related to dysfunction of the ubiquitin-proteasome system that normally leads to the degradation of STEP. Higher level of active STEP is linked to enhanced dephosphorylation of its substrates GluN2B and ERK1/2, CREB inactivation, and a decrease in total levels of GluN2B and brain-derived neurotrophic factor (BDNF). These molecular events are reversed in aged STEP knockout and heterozygous mice, which perform similarly to young control mice in the Morris water maze (MWM) and Y-maze tasks. In addition, administration of the STEP inhibitor TC-2153 to old rats significantly improved performance in a delayed alternation T-maze memory task. In contrast, viral-mediated STEP overexpression in the hippocampus is sufficient to induce memory impairment in the MWM and Y-maze tests, and these cognitive deficits are reversed by STEP inhibition. In old LOU/C/Jall rats, a model of healthy aging with preserved memory capacities, levels of STEP and GluN2B are stable, and phosphorylation of GluN2B and ERK1/2 is unaltered. Altogether, these data suggest that elevated levels of STEP that appear with advancing age in several species contribute to the cognitive declines associated with aging.
[divider]Feel free to share this Yale.[/divider]